Immune checkpoint blockade in combination with stereotactic body radiotherapy in patients with metastatic pancreatic ductal adenocarcinoma.

CONCLUSIONS: The combination of ICI and SBRT has an acceptable safety profile and demonstrates a modest treatment benefit in patients with metastatic PDAC.
PMID: 31996388 [PubMed - as supplied by publisher]

Source: Clinical Cancer Research - January 28, 2020 Category: Cancer & Oncology Authors: Xie C, Duffy A, Brar G, Fioravanti S, Mabry-Hrones D, Walker M, Monge Bonilla C, Wood BJ, Citrin DE, Gil Ramirez EM, Escorcia FE, Redd B, Hernandez JM, Davis JL, Gasmi B, Kleiner D, Steinberg SM, Jones JC, Greten TF Tags: Clin Cancer Res Source Type: research